Is BELDICO still active?

Yes, BELDICO is currently active.

Where is BELDICO registered?

BELDICO's registered address is Aye, Rue André Feher 3, 6900 Marche-en-Famenne, Belgium.

How many employees does BELDICO have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), BELDICO reported 134.4 full-time equivalent employees.

What is BELDICO's annual turnover?

BELDICO's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €17,680,223.

Did BELDICO make a profit or a loss?

BELDICO's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €296,342.

When did BELDICO last file annual accounts?

BELDICO's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is BELDICO B Corp certified?

We have no B Corp certification on file for BELDICO.

Does BELDICO hold Fairtrade certification?

No, BELDICO does not currently hold Fairtrade certification.

BELDICO

Q: When was BELDICO founded?

BELDICO was founded on 27 Nov 1987, making it 38 years old.

Q: What does BELDICO do?

BELDICO's registered main activities are Manufacture of medical and dental instruments and supplies, Manufacture of basic pharmaceutical products, Retail sale of other new goods n.e.c., Manufacture of electro diagnostic devices, such as electro radiographic devices, ultrasonic diagnostic apparatus, CT scintillation nuclear magnetic resonance installations,, Wholesale trade of medical, surgical and dental supplies, Wholesale of measuring, testing and navigating equipment, and Systematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.).

BE 0432.680.178

Copied!

NV/SA

Status

Active

Founded

27 Nov 1987 · 38 yrs

Size

Medium · 134.4 FTE

Abbreviation

BELDICO

Main activity

Manufacture of medical and dental instruments and supplies

Activities

7 activities

Manufacture of medical and dental instruments and suppliesManufacture of basic pharmaceutical productsRetail sale of other new goods n.e.c.Manufacture of electro diagnostic devices, such as electro radiographic devices, ultrasonic diagnostic apparatus, CT scintillation nuclear magnetic resonance installations,Wholesale trade of medical, surgical and dental suppliesWholesale of measuring, testing and navigating equipmentSystematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.)

Financials

Turnover2025

€17.7M-3.8%

Profit / Loss2025

€296K-68.9%

Equity2025

€1.9M+17.6%

2025	2024	2023	2022
€17,680,223-3.8%	€18,381,099+12.2%	€16,388,567+3.1%	€15,896,939
€296,342-68.9%	€951,854+294.1%	€241,511+132.9%	-€733,346
€1,858,005+17.6%	€1,580,451+143.9%	€648,029+51.6%	€427,493
€6,632,015-6.8%	€7,119,847-4.9%	€7,484,124-7.1%	€8,055,071
€251,118-8.1%	€273,156-35.7%	€425,150+410.2%	€83,331
134.4+0.3%	134+3.9%	129+10.3%	117
€131,549-4.1%	€137,172+8%	€127,043-6.5%	€135,871

Frequently asked questions

01What is BELDICO's official registered name?

BELGIAN DIAGNOSTIC COMPANY.

02What is BELDICO's enterprise number (VAT number)?

BE 0432.680.178.

03What is BELDICO's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was BELDICO founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€17,680,223-3.8%	€18,381,099+12.2%	€16,388,567+3.1%	€15,896,939
	€7,000,891+0.4%	€6,974,068+13.7%	€6,133,642+13.7%	€5,393,331
	€463,881-51.5%	€955,675+180%	€341,292+149.9%	-€683,698
	€1,549,770-17.5%	€1,879,034+62.1%	€1,158,879>1000%	€56,130
	€296,342-68.9%	€951,854+294.1%	€241,511+132.9%	-€733,346
	€229,890+175.4%	€83,482-44.4%	€150,151-15.7%	€178,069
Profitability
	8.8%-14.2%	10.2%+44.6%	7.1%>1000%	0.4%
	1.7%-67.6%	5.2%+251.4%	1.5%+131.9%	-4.6%
	15.9%-73.5%	60.2%+61.6%	37.3%+121.7%	-171.5%
	3.5%-68.1%	10.9%+268.4%	3.0%+134.4%	-8.6%
Solvency
	€8,490,597-2.4%	€8,700,875+7%	€8,133,061-4.1%	€8,484,598
	€4,048,902-8.8%	€4,439,008-1.6%	€4,509,985-4.7%	€4,731,504
	€116,0210%	€116,021>1000%	€1130%	€113
	€1,858,005+17.6%	€1,580,451+143.9%	€648,029+51.6%	€427,493
	21.9%+20.5%	18.2%+128%	8.0%+58.1%	5.0%
	€2,621,504-13.2%	€3,021,053-6.9%	€3,244,216-1.8%	€3,303,401
	1.41-26.2%	1.91-61.8%	5.01-35.2%	7.73
	€6,632,015-6.8%	€7,119,847-4.9%	€7,484,124-7.1%	€8,055,071
	3.57-20.8%	4.50-61%	11.55-38.7%	18.84
	2.55-57.8%	6.04+116.4%	2.79+140.4%	-6.92
Liquidity
	€251,118-8.1%	€273,156-35.7%	€425,150+410.2%	€83,331
	€1,642,162-0.5%	€1,650,215-15.1%	€1,943,552+2.9%	€1,889,479
	€1,751,707+29.7%	€1,350,734+44.2%	€936,642-36%	€1,464,464
	€1,289,273-12.4%	€1,471,727+13.4%	€1,297,505-38.2%	€2,098,744
	€4,001,980-2.4%	€4,098,794-3.3%	€4,239,698-10.8%	€4,751,460
	0.86+2.3%	0.84+17.6%	0.71-4.9%	0.75
	-€313,430+17.8%	-€381,318+51.5%	-€785,570+28.6%	-€1,099,656
Efficiency
	36 days+34.8%	27 days+28.6%	21 days-37.9%	34 days
	51 days-6.9%	55 days+9.9%	50 days-29%	70 days
	97 days+11.1%	87 days-16.3%	104 days+13.6%	92 days
	3.76-2.1%	3.84+8.2%	3.55-14.2%	4.14
Profit appropriation
	€98,3340%	€98,3340%	€98,3340%	€98,334
	-€90,430+76.6%	-€386,773+71.1%	-€1,338,627+15.3%	-€1,580,137

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€17,680,223-3.8%	€18,381,099+12.2%	€16,388,567+3.1%	€15,896,939
	€7,000,891+0.4%	€6,974,068+13.7%	€6,133,642+13.7%	€5,393,331
	€463,881-51.5%	€955,675+180%	€341,292+149.9%	-€683,698
	€1,549,770-17.5%	€1,879,034+62.1%	€1,158,879>1000%	€56,130
	€296,342-68.9%	€951,854+294.1%	€241,511+132.9%	-€733,346
	€229,890+175.4%	€83,482-44.4%	€150,151-15.7%	€178,069
Profitability
	8.8%-14.2%	10.2%+44.6%	7.1%>1000%	0.4%
	1.7%-67.6%	5.2%+251.4%	1.5%+131.9%	-4.6%
	15.9%-73.5%	60.2%+61.6%	37.3%+121.7%	-171.5%
	3.5%-68.1%	10.9%+268.4%	3.0%+134.4%	-8.6%
Solvency
	€8,490,597-2.4%	€8,700,875+7%	€8,133,061-4.1%	€8,484,598
	€4,048,902-8.8%	€4,439,008-1.6%	€4,509,985-4.7%	€4,731,504
	€116,0210%	€116,021>1000%	€1130%	€113
	€1,858,005+17.6%	€1,580,451+143.9%	€648,029+51.6%	€427,493
	21.9%+20.5%	18.2%+128%	8.0%+58.1%	5.0%
	€2,621,504-13.2%	€3,021,053-6.9%	€3,244,216-1.8%	€3,303,401
	1.41-26.2%	1.91-61.8%	5.01-35.2%	7.73
	€6,632,015-6.8%	€7,119,847-4.9%	€7,484,124-7.1%	€8,055,071
	3.57-20.8%	4.50-61%	11.55-38.7%	18.84
	2.55-57.8%	6.04+116.4%	2.79+140.4%	-6.92
Liquidity
	€251,118-8.1%	€273,156-35.7%	€425,150+410.2%	€83,331
	€1,642,162-0.5%	€1,650,215-15.1%	€1,943,552+2.9%	€1,889,479
	€1,751,707+29.7%	€1,350,734+44.2%	€936,642-36%	€1,464,464
	€1,289,273-12.4%	€1,471,727+13.4%	€1,297,505-38.2%	€2,098,744
	€4,001,980-2.4%	€4,098,794-3.3%	€4,239,698-10.8%	€4,751,460
	0.86+2.3%	0.84+17.6%	0.71-4.9%	0.75
	-€313,430+17.8%	-€381,318+51.5%	-€785,570+28.6%	-€1,099,656
Efficiency
	36 days+34.8%	27 days+28.6%	21 days-37.9%	34 days
	51 days-6.9%	55 days+9.9%	50 days-29%	70 days
	97 days+11.1%	87 days-16.3%	104 days+13.6%	92 days
	3.76-2.1%	3.84+8.2%	3.55-14.2%	4.14
Profit appropriation
	€98,3340%	€98,3340%	€98,3340%	€98,334
	-€90,430+76.6%	-€386,773+71.1%	-€1,338,627+15.3%	-€1,580,137

2025

2024

2023

2022

Income statement

€17,680,223-3.8%

€18,381,099+12.2%

€16,388,567+3.1%

€15,896,939

€7,000,891+0.4%

€6,974,068+13.7%

€6,133,642+13.7%

€5,393,331

€463,881-51.5%

€955,675+180%

€341,292+149.9%

-€683,698

€1,549,770-17.5%

€1,879,034+62.1%

€1,158,879>1000%

€56,130

€296,342-68.9%

€951,854+294.1%

€241,511+132.9%

-€733,346

€229,890+175.4%

€83,482-44.4%

€150,151-15.7%

€178,069

Profitability

8.8%-14.2%

10.2%+44.6%

7.1%>1000%

0.4%

1.7%-67.6%

5.2%+251.4%

1.5%+131.9%

-4.6%

15.9%-73.5%

60.2%+61.6%

37.3%+121.7%

-171.5%

3.5%-68.1%

10.9%+268.4%

3.0%+134.4%

-8.6%

Solvency

€8,490,597-2.4%

€8,700,875+7%

€8,133,061-4.1%

€8,484,598

€4,048,902-8.8%

€4,439,008-1.6%

€4,509,985-4.7%

€4,731,504

€116,0210%

€116,021>1000%

€1130%

€113

€1,858,005+17.6%

€1,580,451+143.9%

€648,029+51.6%

€427,493

21.9%+20.5%

18.2%+128%

8.0%+58.1%

5.0%

€2,621,504-13.2%

€3,021,053-6.9%

€3,244,216-1.8%

€3,303,401

1.41-26.2%

1.91-61.8%

5.01-35.2%

7.73

€6,632,015-6.8%

€7,119,847-4.9%

€7,484,124-7.1%

€8,055,071

3.57-20.8%

4.50-61%

11.55-38.7%

18.84

2.55-57.8%

6.04+116.4%

2.79+140.4%

-6.92

Liquidity

€251,118-8.1%

€273,156-35.7%

€425,150+410.2%

€83,331

€1,642,162-0.5%

€1,650,215-15.1%

€1,943,552+2.9%

€1,889,479

€1,751,707+29.7%

€1,350,734+44.2%

€936,642-36%

€1,464,464

€1,289,273-12.4%

€1,471,727+13.4%

€1,297,505-38.2%

€2,098,744

€4,001,980-2.4%

€4,098,794-3.3%

€4,239,698-10.8%

€4,751,460

0.86+2.3%

0.84+17.6%

0.71-4.9%

0.75

-€313,430+17.8%

-€381,318+51.5%

-€785,570+28.6%

-€1,099,656

Efficiency

36 days+34.8%

27 days+28.6%

21 days-37.9%

34 days

51 days-6.9%

55 days+9.9%

50 days-29%

70 days

97 days+11.1%

87 days-16.3%

104 days+13.6%

92 days

3.76-2.1%

3.84+8.2%

3.55-14.2%

4.14

Profit appropriation

€98,3340%

€98,334

-€90,430+76.6%

-€386,773+71.1%

-€1,338,627+15.3%

-€1,580,137

BELDICO

Activities

Financials

Frequently asked questions

All locations

All locations